M. A. Tran

680 total citations
35 papers, 517 citations indexed

About

M. A. Tran is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, M. A. Tran has authored 35 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 13 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in M. A. Tran's work include Neuropeptides and Animal Physiology (9 papers), Cardiovascular Syncope and Autonomic Disorders (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). M. A. Tran is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Cardiovascular Syncope and Autonomic Disorders (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). M. A. Tran collaborates with scholars based in France, Canada and United States. M. A. Tran's co-authors include Jean‐Michel Sénard, J L Montastruc, M Berlan, A Rascol, Geneviève Durrieu, P Montastruc, Jean‐Louis Montastruc, Philippe Valet, Olivier Rascol and Christine Damase‐Michel and has published in prestigious journals such as Nature Communications, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

M. A. Tran

34 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. Tran France 14 180 150 139 135 108 35 517
J L Montastruc France 13 154 0.9× 125 0.8× 225 1.6× 85 0.6× 298 2.8× 43 702
J. O. SKARPHEDINSSON Sweden 18 110 0.6× 55 0.4× 137 1.0× 206 1.5× 226 2.1× 32 757
Laura Watson United Kingdom 14 111 0.6× 113 0.8× 117 0.8× 130 1.0× 140 1.3× 43 539
R. R. Abraham United Kingdom 12 119 0.7× 56 0.4× 82 0.6× 49 0.4× 299 2.8× 22 556
Nancy Flattem United States 6 51 0.3× 288 1.9× 164 1.2× 233 1.7× 96 0.9× 7 633
J.S. Kuo Taiwan 12 63 0.3× 35 0.2× 129 0.9× 88 0.7× 90 0.8× 36 419
R. Figdor Australia 6 34 0.2× 77 0.5× 129 0.9× 149 1.1× 170 1.6× 6 558
R. V. Jackson Australia 12 67 0.4× 29 0.2× 119 0.9× 46 0.3× 43 0.4× 23 378
Amy K. Roscoe United States 6 26 0.1× 41 0.3× 235 1.7× 59 0.4× 153 1.4× 10 561
R A Mueller United States 6 96 0.5× 20 0.1× 284 2.0× 85 0.6× 59 0.5× 7 601

Countries citing papers authored by M. A. Tran

Since Specialization
Citations

This map shows the geographic impact of M. A. Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Tran more than expected).

Fields of papers citing papers by M. A. Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Tran. The network helps show where M. A. Tran may publish in the future.

Co-authorship network of co-authors of M. A. Tran

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Tran. A scholar is included among the top collaborators of M. A. Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Tran. M. A. Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Linda, Sandeep Sharma, M. A. Tran, et al.. (2025). Restoration of locomotor function following stimulation of the A13 region in Parkinson’s mouse models. eLife. 12. 1 indexed citations
2.
Tran, M. A., et al.. (2024). Inhibitory medial zona incerta pathway drives exploratory behavior by inhibiting glutamatergic cuneiform neurons. Nature Communications. 15(1). 1160–1160. 5 indexed citations
3.
Sénard, Jean‐Michel, M. Simonetta‐Moreau, & M. A. Tran. (2003). Blood pressure and heart rate variability in patients with essential hyperhidrosis. Clinical Autonomic Research. 13(4). 281–285. 12 indexed citations
4.
Pelat, Michel, Patrick Verwaerde, M. A. Tran, et al.. (2001). Changes in vascular alpha1‐ and alpha2‐adrenoceptor responsiveness by selegiline treatment. Fundamental and Clinical Pharmacology. 15(4). 239–245. 3 indexed citations
5.
Lazartigues, Eric, Christine Brefel‐Courbon, M. A. Tran, J L Montastruc, & Olivier Rascol. (1999). Spontaneously hypertensive rats cholinergic hyper‐responsiveness: central and peripheral pharmacological mechanisms. British Journal of Pharmacology. 127(7). 1657–1665. 19 indexed citations
6.
Brefel, Christine, Eric Lazartigues, M. A. Tran, et al.. (1995). Central cardiovascular effects of acetylcholine in the conscious dog. British Journal of Pharmacology. 116(4). 2175–2182. 12 indexed citations
7.
Galinier, Michel, Jean‐Michel Sénard, Philippe Valet, et al.. (1994). Relationship Between Arterial Blood Pressure Disturbances and Alpha Adrenoceptor Density. Clinical and Experimental Hypertension. 16(3). 373–389. 13 indexed citations
8.
Tran, M. A., François Chollet, Jean‐Michel Sénard, et al.. (1993). The effect of yohimbine on sympathetic responsiveness in essential hypertension. European Journal of Clinical Pharmacology. 44(2). 199–201. 9 indexed citations
9.
10.
Tavernier, Geneviève, et al.. (1992). [Differential regulation of the release of norepinephrine and neuropeptide Y].. PubMed. 85(8). 1137–40. 2 indexed citations
11.
Portillo, María P., M. Reverte, Dominique Langin, et al.. (1991). Effect of a 7‐day treatment with idazoxan and its 2‐methoxy derivative RX 821001 on α2‐adrenoceptors and non‐adrenoceptor idazoxan binding sites in rabbits. British Journal of Pharmacology. 104(1). 190–194. 16 indexed citations
12.
Sénard, Jean‐Michel, Philippe Valet, Geneviève Durrieu, et al.. (1990). Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension. European Journal of Clinical Investigation. 20(6). 613–619. 89 indexed citations
13.
Damase‐Michel, Christine, et al.. (1990). Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 770–777. 19 indexed citations
14.
Galitzky, Jean, et al.. (1990). Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers. European Journal of Clinical Pharmacology. 39(5). 447–51. 26 indexed citations
15.
Sénard, Jean‐Michel, P Barbe, Rosine Guimbaud, et al.. (1990). Decreased High Affinity State in Plateletα2-Adrenoceptors from Diabetic Patients with Orthostatic Hypotension. The Journal of Clinical Endocrinology & Metabolism. 71(2). 311–317. 11 indexed citations
16.
Tran, M. A., et al.. (1989). Ciclétanine et système nerveux sympathique. Etude chez le chien éveillé hypertendu par dénervation sino-aortique.. Archives Des Maladies Du Coeur Et Des Vaisseaux. 82(4). 55–58. 6 indexed citations
17.
Montastruc, J L, et al.. (1989). EFFECT OF APOMORPHINE ON ADRENAL MEDULLARY CATECHOLAMINE LEVELS. Fundamental and Clinical Pharmacology. 3(6). 665–670. 6 indexed citations
18.
Damase‐Michel, Christine, et al.. (1989). Effects of pinacidil on the sympatho‐adrenal system in dogs. British Journal of Pharmacology. 97(4). 1019–1026. 16 indexed citations
19.
Valet, Philippe, et al.. (1988). Rilmenidine (S 3341) and the sympathoadrenal system: adrenoreceptors, plasma and adrenal catecholamines in dogs. Journal of Autonomic Pharmacology. 8(4). 319–326. 20 indexed citations
20.
Bourgoin, S., F. Cesselin, H. Gozlan, et al.. (1987). Chronic Chlorimipramine Does Not Reverse the Reduction of Cerebrospinal Fluid Met-Enkephalin-Like Immunoreactivity in Chronic-Pain Patients. Clinical Neuropharmacology. 10(5). 434–442. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J L Montastruc Breakdown of academic impact, for papers by J. O. SKARPHEDINSSON Breakdown of academic impact, for papers by Laura Watson Breakdown of academic impact, for papers by R. R. Abraham Breakdown of academic impact, for papers by Nancy Flattem Breakdown of academic impact, for papers by J.S. Kuo Breakdown of academic impact, for papers by R. Figdor Breakdown of academic impact, for papers by R. V. Jackson Breakdown of academic impact, for papers by Amy K. Roscoe Breakdown of academic impact, for papers by R A Mueller
Rankless by CCL
2026